Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-16

Clinical Trial Update: Efficacy and Safety of Omalizumab in Bullous Pemphigoid [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of omalizumab in bullous pemphigoid; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Omalizumab (Omalizumab)

Snippet

Sponsor: University of Iowa | Conditions: Bullous Pemphigoid | Phase 4 | Status: COMPLETED | Results posted: 2012-10-16